Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update March 2021

Management of Parkinson’s disease (PD) medicines in patients undergoing elective surgery who are normally maintained on oral PD medicines.

Key Medicine Shortages for March 2021

Summarises the ADTC position on generic prescribing

This update covers local formulary changes and decisions not related to recent SMC advice such as formulary appeals, new drug assessments and formulary section reviews

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

This update covers local formulary changes and decisions not related to recent SMC advice such as formulary appeals, new drug assessments and formulary section reviews.

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary